Collaboration Products. Subject to the terms and conditions of the Collaboration Agreement and of Section 2.5 of this License Agreement, Alnylam hereby grants to Novartis and its Affiliates an exclusive (subject to Alnylam's right (itself or through its Affiliates) to perform its obligations under the Research Collaboration), worldwide, royalty-bearing, sublicensable (subject to Section 3.1(d) of the Collaboration Agreement) right and sublicense under CRT Patent Rights to (i) Discover, Develop, Commercialize or Manufacture Collaboration Products for all applications in the CRT Field, and (ii) to Develop, Commercialize or Manufacture Discovered RNAi Compounds.
Appears in 3 contracts
Samples: Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.)
Collaboration Products. Subject to the terms and conditions of the Collaboration this Agreement (including Sections 3.1(e) and of Section 2.5 of this License Agreement(f)), Alnylam hereby grants to Novartis and its Affiliates an exclusive (subject to Alnylam's right (itself or through its Affiliates) to perform its obligations under the Research Collaboration), worldwide, royalty-bearing, sublicensable (subject to Section 3.1(d) of the Collaboration Agreement)) right and sublicense license under CRT Patent Rights Alnylam Intellectual Property to (i) Discover, Develop, Commercialize or Manufacture Collaboration Products for all applications in the CRT Field, and (ii) to Develop, Commercialize or Manufacture Discovered RNAi Compounds.
Appears in 3 contracts
Samples: Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.)